ClinicalTrials.govpublic full text
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)
acute myelogenous leukemia, single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia, acute myelogenous leukemia (aml) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 867750
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.